Quick Answer: No GLP-1 receptor agonist is currently licensed specifically for fatty liver disease in the UK, but semaglutide and liraglutide show the most promising evidence for reducing hepatic steatosis and inflammation in patients with MASLD/NASH
Concentration Math Insulin Syringe Units (U-100, 100 units = 1 mL) Yield at maintenance: at a 1.2 mg combined dose per week, the vial provides ~3 weeks of dosing (15 mg 1.2 mg/wk = 12.5 weeks at total mass, but draws of 16 units twice a week or 16 units once a week land at ~3 weeks of practical use given common dosing patterns)
Helicobacter pylori: A ros-inducing bacterial species in the stomach
For insulin, that relationship between the syringe marking and the medication potency is straightforward because insulin is standardized at 100 units per mL
Johri AM, Heyland DK, Htu MF, Crawford B, Spence JD, Elsevier (2014) Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: evidence and controversies
The aim is a comfortable deficit you can sustain for months, not a starvation contest you abandon in three weeks